Literature DB >> 6992311

Criteria for hepatic transplantation in cirrhosis.

D Houssin, D Franco, M B Corlette, H Bismuth.   

Abstract

Among the patients considered for hepatic transplantation, cirrhosis should be theoretically the best indication. Results so far are disappointing because the patients who have undergone a transplantation had end stage liver disease. When gastrointestinal bleeding, renal failure, coagulopathy and encephalopathy are used as criteria, one can accurately select patients who will die from cirrhosis within one month. Our results for those who had a liver graft in this group are poor. Criteria were then selected to identify a less dramatically ill group of patients with cirrhosis. These patients have residual poor liver function after surviving acute severe complications and have a spontaneous survival of less than one year. The results of liver transplantation in two patients in this group are encouraging.

Entities:  

Mesh:

Year:  1980        PMID: 6992311

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  4 in total

1.  Pediatric Liver Transplantation Under Therapy With Cyclosporin-A and Steroids.

Authors:  J J Malatack; B J Zitelli; J C Gartner; B W Shaw; S Iwatsuki; T E Starzl
Journal:  Transplant Proc       Date:  1983-03       Impact factor: 1.066

Review 2.  Evolution of liver transplantation.

Authors:  T E Starzl; S Iwatsuki; D H Van Thiel; J C Gartner; B J Zitelli; J J Malatack; R R Schade; B W Shaw; T R Hakala; J T Rosenthal; K A Porter
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

3.  Orthotopic liver transplantation in children: two-year experience with 47 patients.

Authors:  J C Gartner; B J Zitelli; J J Malatack; B W Shaw; S Iwatsuki; T E Starzl
Journal:  Pediatrics       Date:  1984-07       Impact factor: 7.124

4.  Choosing a pediatric recipient for orthotopic liver transplantation.

Authors:  J J Malatack; D J Schaid; A H Urbach; J C Gartner; B J Zitelli; H Rockette; J Fischer; T E Starzl; S Iwatsuki; B W Shaw
Journal:  J Pediatr       Date:  1987-10       Impact factor: 4.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.